share_log

SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-KNIGHT THERAPEUTICS INC.(9.97%),KNIGHT THERAPEUTICS INTERNATIONAL S.A.(9.97%)

SEC announcement ·  May 8 07:21
Summary by Futu AI
Knight Therapeutics Inc., a Canadian pharmaceutical company, and its subsidiary, Knight Therapeutics International S.A., based in Uruguay, have jointly filed an amended Schedule 13G/A with the SEC, disclosing a significant stake in 60 Degrees Pharmaceuticals. The filing, dated May 3, 2024, indicates that Knight Therapeutics Inc. has transferred 1,153,897 shares of common stock from its subsidiary, resulting in direct beneficial ownership of 9.97% of 60 Degrees Pharmaceuticals' issued and outstanding shares as of April 1, 2024. The shares were previously held directly by Knight Therapeutics International S.A. The filing asserts that the shares are not intended for the purpose of changing or influencing the control of 60 Degrees Pharmaceuticals, nor in connection with any transaction having such purpose or effect.
Knight Therapeutics Inc., a Canadian pharmaceutical company, and its subsidiary, Knight Therapeutics International S.A., based in Uruguay, have jointly filed an amended Schedule 13G/A with the SEC, disclosing a significant stake in 60 Degrees Pharmaceuticals. The filing, dated May 3, 2024, indicates that Knight Therapeutics Inc. has transferred 1,153,897 shares of common stock from its subsidiary, resulting in direct beneficial ownership of 9.97% of 60 Degrees Pharmaceuticals' issued and outstanding shares as of April 1, 2024. The shares were previously held directly by Knight Therapeutics International S.A. The filing asserts that the shares are not intended for the purpose of changing or influencing the control of 60 Degrees Pharmaceuticals, nor in connection with any transaction having such purpose or effect.

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.